KRAS and neoplasm: PDAC with KRAS mutations is accompanied by nerve infiltration in the early stages of tumor progression, which is a core driving force for postoperative recurrence and poor prognosis.[22] However, the mechanisms underlying the PNI in KRAS‐mutant PDAC remain unclear.